Key Highlights

  • On 29 October 2026, Skin Elements Limited (ASX:SKN) was quoted at AUD 0.002, with the daily change shown as unchanged. This article covers farmlands distribution agreement, regulatory steps for eco-nurture and the company’s wider disclosures.
  • Skin Elements signed an initial NZD 600,000 ECO-Nurture order with New Zealand distributor Farmlands.
  • Its September quarter included a NZD 150,000 first delivery, an AUD 900,000 placement and a renewed operating review.

Skin Elements Limited (ASX:SKN) has reported financial and commercial developments relevant to its FY26 and FY27 activities. On 29 October 2026, Skin Elements Limited (ASX:SKN) was quoted at AUD 0.002, with the daily change shown as unchanged. Skin Elements signed an initial NZD 600,000 ECO-Nurture order with New Zealand distributor Farmlands. Its September quarter included a NZD 150,000 first delivery, an AUD 900,000 placement and a renewed operating review. The disclosures also address financing and quarterly cash flows and product development and r&d.

Farmlands Distribution Agreement

Skin Elements executed an exclusive distribution agreement with Farmlands Co-Operative Society following product trials in New Zealand’s kiwifruit industry. The initial order for ECO-Nurture was valued at NZD 600,000 before New Zealand GST. A first delivery valued at NZD 150,000 was completed during the September quarter, with corresponding receipts of about AUD 117,000. The company was working on a second NZD 150,000 delivery and intended to complete the balance of the initial order subsequently.

Regulatory Steps for ECO-Nurture

The company described ECO-Nurture as a horticultural plant biostimulant based on plant-derived ingredients. It continued work toward approval under New Zealand’s Agricultural Compounds and Veterinary Medicines framework. Skin Elements and Farmlands envisaged a subsequent national sales agreement once the relevant approval was obtained. The initial export agreement and completed deliveries were disclosed commercial events; the broader proposed national arrangement was dependent on the regulatory step and had not yet been confirmed in the quarterly announcement.

Financing and Quarterly Cash Flows

Skin Elements received AUD 900,000 in proceeds from a placement announced in June 2026. The company reported customer receipts of AUD 123,000 for the September quarter, including the approximately AUD 117,000 associated with the Farmlands delivery. Net cash used in operating activities was AUD 272,000, compared with AUD 874,000 in the June quarter. Cash and cash equivalents at 30 September 2026 totalled AUD 1.455 million. The quarter also included review of expenditure controls and operating arrangements.

Manufacturing and Customer Engagement

Following board changes, Skin Elements began a review of supply chains, contract manufacturing, laboratories and administrative spending. It engaged a preferred contract manufacturing laboratory and implemented additional expenditure approvals. Separately, the group launched a new online shop featuring its PapayaActivs range and began contacting 34,816 registered customers through an email campaign. These activities were disclosed as steps within the company’s commercial and operational review, rather than quantified new revenue beyond the reporting-period receipts.

Product Development and R&D

The Soléo high-performance sunscreen line continued toward production following formulation changes, subject to testing and relevant regulatory requirements. Skin Elements also assessed an FY26 research and development tax incentive refund of AUD 502,090, against which an AUD 288,000 advance had previously been received. The net balance was expected during the December quarter, following repayment of the advance. The company also reported attending the IFSCC cosmetics congress in Perth as part of industry engagement.

Key Insights

Overall, Skin Elements Limited reported skin Elements signed an initial NZD 600,000 ECO-Nurture order with New Zealand distributor Farmlands. its September quarter included a NZD 150,000 first delivery, an AUD 900,000 placement and a renewed operating review. The announcement also addresses financing and quarterly cash flows, manufacturing and customer engagement and product development and r&d. These are company-reported results and planned activities for their stated periods; announced targets, proposed transactions and pending approvals remain distinct from completed outcomes.